Flow cytometry is widely used for the immunological characterization of hematopoietic malignancies. Discrimination of normal and malignant cellular immunophenotypes is the most critical step in data analysis, especially if multi‐color analysis is performed on highly heterogenous cell suspensions. We therefore investigated, whether adaptive, simultaneous multiparameter gating allowed automated, operator independent analysis of data obtained from the immunophenotyping of blood or bone marrow samples with regard to the presence of non‐Hodgkin lymphoma cells. The identification of physiological and malignant cells was achieved by predefining population boundaries, based on the expectations of the population’s location in two‐dimensional dot plo...
Large-scale immune monitoring is becoming routinely used in clinical trials to identify determinants...
Data obtained with cytometry are increasingly complex and their interrogation impacts the type and q...
Large-scale immune monitoring is becoming routinely used in clinical trials to identify determinants...
B-cell Non-Hodgkin lymphomas (B-NHL) are a wide and highly heterogeneous group of malignancies, char...
AbstractObjectiveFlow cytometry is becoming an important tool in the characterization of different h...
Hematogones are precursors of B-lymphocytes detected in small numbers in the bone marrow. Flow cytom...
Ever since hematopoietic cells became “events” enumerated and characterized in suspension by cell co...
Manual analysis of flow cytometry data and subjective gate-border decisions taken by individuals con...
International audienceEver since hematopoietic cells became "events" enumerated and characterized in...
The study of normal or malignant haematopoiesis requires the analysis of heterogeneous cell populati...
In recent years the volume and complexity of flow cytometry data has increased substantially. This h...
Immunophenotyping is a routine method to evaluate B-cell non-Hodgkin lymphomas. Flow cytometry plays...
The study of normal or malignant haematopoiesis requires the analysis of heterogeneous cell populati...
AbstractMulti-parametric flow cytometry is a key technology for characterization of immune cell phen...
International audienceMulti-parametric flow cytometry is a key technology for characterization of im...
Large-scale immune monitoring is becoming routinely used in clinical trials to identify determinants...
Data obtained with cytometry are increasingly complex and their interrogation impacts the type and q...
Large-scale immune monitoring is becoming routinely used in clinical trials to identify determinants...
B-cell Non-Hodgkin lymphomas (B-NHL) are a wide and highly heterogeneous group of malignancies, char...
AbstractObjectiveFlow cytometry is becoming an important tool in the characterization of different h...
Hematogones are precursors of B-lymphocytes detected in small numbers in the bone marrow. Flow cytom...
Ever since hematopoietic cells became “events” enumerated and characterized in suspension by cell co...
Manual analysis of flow cytometry data and subjective gate-border decisions taken by individuals con...
International audienceEver since hematopoietic cells became "events" enumerated and characterized in...
The study of normal or malignant haematopoiesis requires the analysis of heterogeneous cell populati...
In recent years the volume and complexity of flow cytometry data has increased substantially. This h...
Immunophenotyping is a routine method to evaluate B-cell non-Hodgkin lymphomas. Flow cytometry plays...
The study of normal or malignant haematopoiesis requires the analysis of heterogeneous cell populati...
AbstractMulti-parametric flow cytometry is a key technology for characterization of immune cell phen...
International audienceMulti-parametric flow cytometry is a key technology for characterization of im...
Large-scale immune monitoring is becoming routinely used in clinical trials to identify determinants...
Data obtained with cytometry are increasingly complex and their interrogation impacts the type and q...
Large-scale immune monitoring is becoming routinely used in clinical trials to identify determinants...